Literature DB >> 20123152

Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil.

Karina Eugênia Schimith Bier1, Simone Oliveira Luiz, Mara Cristina Scheffer, Ana Cristina Gales, Maria Cristina Paganini, Agnaldo José do Nascimento, Evelyn Carignano, Libera Maria Dalla Costa.   

Abstract

BACKGROUND: In the last few years, carbapenem-resistant Acinetobacter baumannii isolates (CR-AB) have been identified worldwide. The first description of OXA-23-producing A baumannii in Brazil was from the city of Curitiba in 2003. The aim of the present study was to evaluate the persistence and dissemination of the first OXA-23-producing A baumannii clone isolated from patients in Hospital de Clinicas, Curitiba, Brazil.
METHODS: An antimicrobial susceptibility profile of the isolates was determined by the standard agar dilution method. Molecular detection of beta-lactamase genes was done by polymerase chain reaction. The clonal relationship of the isolates was analyzed by pulsed-field gel electrophoresis (PFGE). Epidemiologic and clinical features were evaluated as well.
RESULTS: Genotypic analysis of 172 CR-AB isolates by PFGE identified 3 distinct major PFGE clusters (A, B, and C, accounting for 36, 69, and 65 isolates, respectively). All isolates carried the bla(OXA-23)-like gene and were multidrug-resistant, but were susceptible to tigecycline and polymixin B. The mortality rate related to CR-AB infection was 45.4%, and ventilator-associated pneumonia and bloodstream infections were the most frequent clinical manifestations.
CONCLUSIONS: The presence of 3 clones among the CR-AB isolates suggests that cross-transmission was the main mechanism responsible for dissemination of OXA-23 producers. PFGE pattern A was genotypically similar to that of the first OXA-23-producing A baumannii clone identified in Curitiba in 1999. This clone persisted in the same hospital until April 2004. The presence of the bla(OXA-)23-like gene was the main mechanism associated with carbapenem resistance among the isolates studied. Copyright (c) 2010 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20123152     DOI: 10.1016/j.ajic.2009.09.012

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  12 in total

1.  Severe infection in a lung transplant recipient caused by donor-transmitted carbapenem-resistant Acinetobacter baumannii.

Authors:  N Martins; I S Martins; W V de Freitas; J A de Matos; A C G Magalhães; V B C Girão; R C S Dias; T C de Souza; F L P C Pellegrino; L D Costa; C H R Boasquevisque; S A Nouér; L W Riley; G Santoro-Lopes; B M Moreira
Journal:  Transpl Infect Dis       Date:  2011-12-14       Impact factor: 2.228

2.  High prevalence of carbapenem-resistant Acinetobacter baumannii carrying the blaOXA-143 gene in Brazilian hospitals.

Authors:  Charline S Antonio; Patrícia R Neves; Micheli Medeiros; Elsa M Mamizuka; Maria R Elmor de Araújo; Nilton Lincopan
Journal:  Antimicrob Agents Chemother       Date:  2010-12-13       Impact factor: 5.191

3.  Emergence of Acinetobacter baumannii international clone II in Brazil: reflection of a global expansion.

Authors:  Natacha Martins; Libera Dalla-Costa; Aline Almeida Uehara; Lee Woodland Riley; Beatriz Meurer Moreira
Journal:  Infect Genet Evol       Date:  2013-10-10       Impact factor: 3.342

4.  First report of NDM-1-producing Acinetobacter baumannii sequence type 25 in Brazil.

Authors:  Marcelo Pillonetto; Lavinia Arend; Eliana Carolina Vespero; Marsileni Pelisson; Thiago Pavoni Gomes Chagas; Ana Paula D'Alincourt Carvalho-Assef; Marise Dutra Asensi
Journal:  Antimicrob Agents Chemother       Date:  2014-10-06       Impact factor: 5.191

5.  Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study.

Authors:  Alexandre R Marra; Luis Fernando Aranha Camargo; Antonio Carlos Campos Pignatari; Teresa Sukiennik; Paulo Renato Petersen Behar; Eduardo Alexandrino Servolo Medeiros; Julival Ribeiro; Evelyne Girão; Luci Correa; Carla Guerra; Carlos Brites; Carlos Alberto Pires Pereira; Irna Carneiro; Marise Reis; Marta Antunes de Souza; Regina Tranchesi; Cristina U Barata; Michael B Edmond
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

6.  Global assessment of antimicrobial susceptibility among Gram-negative organisms collected from pediatric patients between 2004 and 2012: results from the Tigecycline Evaluation and Surveillance Trial.

Authors:  Sue C Kehl; Michael J Dowzicky
Journal:  J Clin Microbiol       Date:  2015-02-04       Impact factor: 5.948

7.  Multidrug-resistant Acinetobacter baumannii: differential adherence to HEp-2 and A-549 cells.

Authors:  Gabrielle Limeira Genteluci; Daniela Betzler Cardoso Gomes; Daniella Pereira; Marta de Campos Neves; Maria José de Souza; Karyne Rangel; Maria Helena Simões Villas Bôas
Journal:  Braz J Microbiol       Date:  2020-03-16       Impact factor: 2.476

8.  Carbapenem-resistant Acinetobacter ventilator-associated pneumonia: Clinical characteristics and outcome.

Authors:  Mohan Gurjar; Saurabh Saigal; Arvind Kumar Baronia; Bhaskar P Rao; Afzal Azim; Banani Poddar; Ratender Kumar Singh
Journal:  Indian J Crit Care Med       Date:  2013-05

9.  Parenteral colistin for the treatment of severe infections: a single center experience.

Authors:  Marcos Toshyiuki Tanita; Claudia Maria Dantas de Maio Carrilho; Joseani Pascual Garcia; Josiane Festti; Lucienne Tibery Queiroz Cardoso; Cintia Magalhães Carvalho Grion
Journal:  Rev Bras Ter Intensiva       Date:  2013 Oct-Dec

10.  Prevalence of Acinetobacter baumannii bacteremia in intensive care units of Ibn Rochd University Hospital, Casablanca.

Authors:  Assiya El Kettani; Fakhreddine Maaloum; Idrissa Diawara; Khalid Katfy; Nadia Harrar; Khalid Zerouali; Houria Belabbes; Naima Elmdaghri
Journal:  Iran J Microbiol       Date:  2017-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.